4-chloromethyl-2-(furan-3-yl)oxazole

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 4-chloromethyl-2-(furan-3-yl)oxazole
• 英文别名: 4-chloromethyl-2-(3-furyl)oxazole；4-(chloromethyl)-2-(furan-3-yl)-1,3-oxazole
• 化学式: C₈H₆ClNO₂
• 分子量: 183.594
• InChiKey: UMISUZRKWUPTQB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  39.2
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  4-[3-(1H-imidazol-1-yl)propyl]phenol 、 4-chloromethyl-2-(furan-3-yl)oxazole 以to give 4-[4-[3-(1-imidazolyl)propyl]phenoxymethyl]-2-(3-furyl)oxazole的产率得到4-[4-[3-(1-imidazolyl)propyl]phenoxymethyl]-2-(furan-3-yl)oxazole
  参考文献：
  名称：

  Heterocyclic compounds, their production and use

  摘要：

  通式（I）所代表的杂环化合物，其中R代表可选择性取代的芳香杂环基团；X代表氧原子、可选择性氧化的硫原子、—C(═O)—或—CH(OH)—；Y代表CH或N；m表示0到10的整数；n表示1到5的整数；环状基团代表可选择性取代的芳香唑基团；环A可选择性进一步取代，或其盐。化合物（I）具有抑制酪氨酸激酶的作用，可用作抗肿瘤剂。

  公开号：

  US06211215B1
• 作为产物：
  描述：

  methyl 2-(furan-3-yl)-1,3-oxazole-4-carboxylate 在 lithium aluminium tetrahydride 、 氯化亚砜 作用下， 以 四氢呋喃 、 二氯甲烷 为溶剂， 反应 2.0h， 生成 4-chloromethyl-2-(furan-3-yl)oxazole
  参考文献：
  名称：

  Discovery of the disubstituted oxazole analogues as a novel class anti-tuberculotic agents against MDR- and XDR-MTB

  摘要：

  A high-throughput screening effort on 45,000 compounds resulted in the discovery of a disubstituted oxazole as a new structural class inhibitor of Mycobacterium tuberculosis (Mtb). In order to improve the activity and investigate the SAR of this scaffold, a series of disubstituted azole analogues have been designed and synthesized. The newly synthesized compounds 1a-y were evaluated for their in vitro anti-TB activity versus replicating, multi-and extensive drug resistant Mtb strains. All the compounds, except 1o, 1p and 1q, showed potent anti-TB activity with MIC of 1-64 mg/L. The test of broad spectrum panel revealed that this series are specific to Mtb. The cytotoxicity assessment indicated that the compounds were not cytotoxic against HEK 293 cells. The compounds could have a novel mechanism to anti-Mtb as they can inhibit drug sensitive and drug resistant Mtb. (C) 2015 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2015.09.072

文献信息

• US6211215B1
  申请人：——

  公开号：US6211215B1

  公开（公告）日：2001-04-03